Institut für Humangenetik, D-45122 Essen, Germany.
Brief Funct Genomics. 2010 Jul;9(4):347-53. doi: 10.1093/bfgp/elq014. Epub 2010 Jun 15.
Recent data have revealed that the paradigmatic tumour suppressor gene RB1 on chromosome 13 is preferentially expressed from the maternal allele. Imprinted expression of RB1 is linked to a differentially methylated CpG island in intron 2 of this gene (CpG 85). On the paternal chromosome, CpG 85 is unmethylated and acts as a weak promoter of an alternative RB1 transcript. Paternal mRNA levels are probably reduced as the result of transcriptional interference of the regular promoter and the alternative promoter on this chromosome. CpG 85 is part of a truncated processed pseudogene (KIAA0649P) that integrated into the RB1 gene prior to the speciation of extant primates. It is plausible that differential penetrance and variation of age at diagnosis, which have been observed in patients with hereditary and non-hereditary retinoblastoma, respectively, are a consequence of imprinted expression of the RB1 gene. Interestingly, RB1 is imprinted in the same direction as CDKN1C, which operates upstream of RB1. The imprinting of two components of the same pathway indicates that there has been strong evolutionary selection for maternal inhibition of cell proliferation.
最近的数据表明,13 号染色体上的典型肿瘤抑制基因 RB1 优先从母本等位基因表达。RB1 的印迹表达与该基因内含子 2 中一个差异甲基化的 CpG 岛(CpG85)有关。在父本染色体上,CpG85 未甲基化,作为 RB1 转录本的弱启动子起作用。由于该染色体上常规启动子和替代启动子的转录干扰,父本 mRNA 水平可能降低。CpG85 是一个截断的加工假基因(KIAA0649P)的一部分,该假基因在现存灵长类动物分化之前就整合到 RB1 基因中。遗传性和非遗传性视网膜母细胞瘤患者的诊断年龄分别存在不同的外显率和变异性,这可能是 RB1 基因印迹表达的结果。有趣的是,RB1 的印迹方向与 RB1 上游的 CDKN1C 相同。同一途径的两个组成部分的印迹表明,母系抑制细胞增殖在进化选择中具有很强的优势。